Matthew Baker, Ph.DFounder

United States - Greater Cambridge Area

::: GLOBAL SCIENCE & BUSINESS DEVELOPMENT EXECUTIVE :::

Global reputation for driving immunology advancements with a special focus on immunotherapy, small molecule oncology drugs and large molecule drug immunogenicity. Impressive track record of producing novel and proprietary technologies for engineering antibodies and assessing drug immunogenicity. Knowledgeable in small molecule drug discovery/development, antibody drug conjugates and experienced in preclinical drug development programs that have entered clinical trials.

Respected for negotiating 150+ business deals, leading teams of 60+ staff members, and controlling multimillion-dollar budgets. Exceptionally well-versed in all aspects of strategic business development with an impressive track record of generating multimillion-dollar turnover and expanding revenue streams. Highly effective in simplifying complex concepts and delivering persuasive presentations to investors. History of identifying and drafting strategic business plans for M&A targets.

Successful entrepreneur with extensive experience in the development, mentoring, and leadership of personnel. Authored 30+ publications and generated 21 published patents. Invited to speak at 50+ global conferences.

::: SIGNATURE STRENGTHS :::

• Proprietary Technologies
• Research & Development
• Budgeting & Cost Controls
• Business Development & Planning
• Contract Preparations, Negotiations, & Reviews
• Project Management
• Strategic Planning
• Cross-Functional Team Leadership
• Performance Improvements & Quality Management
• Investor & Vendor Relationship Cultivation